Clara Fonteneau
Overview
Explore the profile of Clara Fonteneau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee K, Ji J, Fonteneau C, Berkovitch L, Rahmati M, Pan L, et al.
PLoS Biol
. 2024 Sep;
22(9):e3002808.
PMID: 39316635
Neural activity and behavior vary within an individual (states) and between individuals (traits). However, the mapping of state-trait neural variation to behavior is not well understood. To address this gap,...
2.
Moujaes F, Ji J, Rahmati M, Burt J, Schleifer C, Adkinson B, et al.
Elife
. 2024 Apr;
13.
PMID: 38629811
Background: Ketamine has emerged as one of the most promising therapies for treatment-resistant depression. However, inter-individual variability in response to ketamine is still not well understood and it is unclear...
3.
Wannan C, Nelson B, Addington J, Allott K, Anticevic A, Arango C, et al.
Schizophr Bull
. 2024 Mar;
50(3):496-512.
PMID: 38451304
This article describes the rationale, aims, and methodology of the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). This is the largest international collaboration to date that will develop algorithms to predict...
4.
Berkovitch L, Lee K, Ji J, Helmer M, Rahmati M, Demsar J, et al.
medRxiv
. 2024 Jan;
PMID: 38168378
Importance: Understanding the mechanisms of major depressive disorder (MDD) improvement is a key challenge to determine effective personalized treatments. Objective: To perform a secondary analysis quantifying neural-to-symptom relationships in MDD...
5.
Lee K, Ji J, Fonteneau C, Berkovitch L, Rahmati M, Pan L, et al.
bioRxiv
. 2023 Oct;
PMID: 37790400
Neural activity and behavior vary within an individual (states) and between individuals (traits). However, the mapping of state-trait neural variation to behavior is not well understood. To address this gap,...
6.
Howell A, Warrington S, Fonteneau C, Cho Y, Sotiropoulos S, Murray J, et al.
bioRxiv
. 2023 Aug;
PMID: 37546767
Each cortical area has a distinct pattern of anatomical connections within the thalamus, a central subcortical structure composed of functionally and structurally distinct nuclei. Previous studies have suggested that certain...
7.
Kohler C, Wolf D, Abi-Dargham A, Anticevic A, Cho Y, Fonteneau C, et al.
Biol Psychiatry Glob Open Sci
. 2023 Jul;
3(3):340-350.
PMID: 37519466
The phenotype of schizophrenia, regardless of etiology, represents the most studied psychotic disorder with respect to neurobiology and distinct phases of illness. The early phase of illness represents a unique...
8.
Ji J, Demsar J, Fonteneau C, Tamayo Z, Pan L, Kraljic A, et al.
Front Neuroinform
. 2023 Apr;
17:1104508.
PMID: 37090033
Introduction: Neuroimaging technology has experienced explosive growth and transformed the study of neural mechanisms across health and disease. However, given the diversity of sophisticated tools for handling neuroimaging data, the...
9.
Ji J, Helmer M, Fonteneau C, Burt J, Tamayo Z, Demsar J, et al.
Elife
. 2022 Apr;
11.
PMID: 35380951
No abstract available.
10.
Abi-Dargham A, Javitch J, Slifstein M, Anticevic A, Calkins M, Cho Y, et al.
Schizophr Bull
. 2021 Aug;
48(1):199-210.
PMID: 34423843
Decades of research have highlighted the importance of optimal stimulation of cortical dopaminergic receptors, particularly the D1R receptor (D1R), for prefrontal-mediated cognition. This mechanism is particularly relevant to the cognitive...